Throughout our in vivo experiment, CEL upregulated Ppargc1a gene expression that was suppressed by WD/FG, resembling liver-specific-deficient PGC-1α mice with manifested hepatic steatosis (Rodgers et al., 2005). The gene discussed is PPARGC1A; the disease is Wilson disease.